COVID-19 — Italy
– The hydroxychloroquine arm of the Solidarity Trial, which seeks to find an effective COVID-19 treatment, is being stopped. The decision is based on evidence from the Solidarity Trial, the UK’s Recovery trial and a Cochrane review of other evidence on hydroxychloroquine. Data show that hydroxychloroquine does not result in the reduction of mortality of hospitalised COVID-19 patients, when compared with standard of care.
– Dr Tedros announced the roll out of the WHO Academy, a major new
…
